Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is an 8-week open label study of bupropion SR in the treatment of youth with bipolar
depression with adequate mood stabilization. All youth will be closely monitored for
treatment emergent manic activation and drug-drug interactions with ongoing antimanic agents.
The main objective of this study is to assess the safety and effectiveness of bupropion SR in
the treatment of bipolar depression in children and adolescents.